Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

Bibliographic Details
Main Authors:	Baden, L.R (Author), Desjardins, M. (Author), Sherman, A.C (Author)
Format:	Article
Language:	English
Published:	W.B. Saunders 2022
Subjects:	adaptive immunity age Antibody Formation antibody production antibody response cellular immunity chronic disease coronavirus disease 2019 COVID-19 COVID-19 Vaccines disease severity drug efficacy drug use host cell human Humans humoral immunity immune response immunosuppressive treatment infection control infection prevention infection risk nonhuman outcome assessment passive immunization public health problem randomized controlled trial (topic) Review SARS-CoV-2 SARS-CoV-2 vaccine Serologic diagnostics Severe acute respiratory syndrome coronavirus 2 social status study design tozinameran vaccination reaction vaccine Vaccines virus transmission
Online Access:	View Fulltext in Publisher

View Fulltext in Publisher

Similar Items